Six reasons why Medicaid MCOs are killing it on the exchange.

Partner, Health & Life Sciences, Oliver Wyman

Efforts that companies are making to provide more effective health information for vulnerable individuals within their employee populations.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Leaders of financial investment firms share their views on funding companies that provide health information to vulnerable populations.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A perspective on how pediatric healthcare providers are changing their financial and care models in the evolving value-based market to lower costs and improve outcomes in children’s health.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Trion/MMA

Insights into how hospital systems can manage Medicaid populations without abandoning their mission – or their bottom line.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Insights in your inbox

Subscribe

Access here our full series examining the increasing role providers are playing in government programs and risk management.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

More and more, we are seeing health systems and physician groups move up the value chain and become risk managers, rather than volume-drivers.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

For states already struggling to balance their budgets, adoption of near-final federal rules for Medicaid are likely to pose significant burdens.

Partner, Health & Life Sciences, Oliver Wyman

New guidance from the Centers for Medicare & Medicaid Services ends prolonged confusion over Medicaid pharmacy reimbursements.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

Physicians have to view a redesigned compensation package as a mutual benefit to them and the health system to spur real change.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More